Men's Health Topics

Prostate Information

Treating Asymptomatic and Symptomatic Prostate Cancer
- Keyhole Surgery for Prostate Cancer
- Treating Fast Growing Prostate Cancers
- Prostate Cancer Explained
- Prostate Cancer Exam: What's the Controversy About?
- Hormonal Therapy for Prostate Cancer
- Bone Complications in Prostate Cancer
- Cancer and Cancer Treatment: Can it Affect Sleep?  healthology.com

Celebrex Plus Lipitor Could Fight Prostate Cancer
Combining painkiller with statin slows tumor progression, mouse study suggests   "Monday, April 14, 2008 (HealthDay News) -- Two widely used drugs -- one lowers cholesterol and one is an anti-inflammatory -- may be useful in controlling prostate cancer.  New research being presented at the American Association for Cancer Research annual meeting in San Diego finds that the painkiller Celebrex and the statin Lipitor, when used together or alone, can stop early prostate cancer before it becomes deadly.  The study was conducted in mice so the idea isn't yet ready for clinical use, but experts said these preliminary results did look promising."  Medlineplus

MRI Can Be Predictor of Post-Treatment Prostate Cancer Spread
Those having radiation therapy may want to request more aggressive therapy, study finds  (The study was published in the April issue of the journal Radiology.)  "Tuesday, March 25, 2008 (HealthDay News) -- Magnetic resonance imaging (MRI) can help predict the risk of cancer recurrence in prostate cancer patients who are about to have radiation therapy, a new U.S. study says.  (In 2008, it's estimated that more than 186,320 new cases of prostate cancer - mostly in men over age 65 - will be diagnosed in the United States, according to the National Cancer Institute. When prostate cancer is diagnosed and treated early, the five-year survival rate is almost 100 percent. But the survival rate drops significantly once cancer spreads or recurs beyond the prostate.)"     Medlineplus

MRI Predicts Prostate Cancer Prognosis 
"The study determined that the presence and degree of extracapsular extension -- the spread of cancer beyond the membrane that surrounds the prostate gland -- seen on the pre-treatment MR images was an important predictor of the cancer recurring and spreading after the treatment. Specifically, results show patients with extracapsular extension greater than five millimeters -- about the diameter of a pencil eraser -- were more likely to have the cancer come back and spread." Radiology, 2008;247 Ivanhoe

Home | Contact |  Dentist | Gynecologist | What's New | Site Map
Interventional Radiologist | Insurance | Research | Cosmetic Surgeon
Men | Women

Return to Top